{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:32:38Z","timestamp":1794619958359,"version":"4.9.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Low-dose methotrexate (MTX) is a standard treatment for ectopic pregnancy. While generally safe, it can rarely cause life-threatening hematologic toxicity. The mechanisms underlying these severe reactions in patients without traditional risk factors are poorly understood. We report a case of severe pancytopenia and systematically analyze the literature to characterize this rare but critical complication in MTX treatment for ectopic pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Presentation<\/jats:title><jats:p>A 24-year-old woman received a single 50\u00a0mg\/m<jats:sup>2<\/jats:sup> dose of MTX for a persistent ectopic pregnancy while on concurrent benzathine penicillin therapy for syphilis. Within 24\u00a0h, she developed nausea, vomiting, and facial edema, rapidly progressing to severe mucositis and life-threatening pancytopenia with absolute neutrophil count nadir of 0.1 \u00d7 10<jats:sup>9<\/jats:sup>\/L, platelet nadir of 8 \u00d7 10<jats:sup>9<\/jats:sup>\/L and hemoglobin nadir of 76\u00a0g\/L. Investigations revealed delayed MTX clearance and a heterozygous methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, a known genetic risk factor for MTX toxicity. A diagnosis of MTX toxicity was made, and she fully recovered after intensive supportive care including hydration, urine alkalinization, calcium leucovorin rescue, hematopoietic growth factors, and antibiotics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Severe MTX toxicity following low-dose treatment for ectopic pregnancy is a rare but potentially fatal complication, with 3 deaths among 16 reviewed cases. Our analysis suggests a multifactorial etiology involving genetic predisposition and pharmacokinetic interactions. The MTHFR C677T variant compromises folate metabolism, while concurrent medications like benzathine penicillin may impair MTX renal clearance through competitive inhibition of organic anion transporters. Early symptom onset precedes standard monitoring schedules, necessitating enhanced clinical vigilance and consideration of pharmacogenetic factors and drug interactions in clinical practice.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1671369","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:33:50Z","timestamp":1759383230000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Severe hematologic toxicity after low-dose methotrexate in ectopic pregnancy: role of MTHFR polymorphism and drug interaction - a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaojie","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangjie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.11604\/pamj.2021.38.17.27507","article-title":"Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report","volume":"38","author":"Bayraktar","year":"2021","journal-title":"Pan Afr. Med. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/OGX.0000000000000492","article-title":"New evidence to guide ectopic pregnancy diagnosis and management","volume":"72","author":"Brady","year":"2017","journal-title":"Obstetrical and Gynecol. Surv."},{"key":"B3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00280-016-3043-5","article-title":"Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses","volume":"78","author":"Campbell","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"bcr0320126023","DOI":"10.1136\/bcr-03-2012-6023","article-title":"Life-threatening complications following multidose methotrexate for medical management of ectopic pregnancy","volume":"2012","author":"Dasari","year":"2012","journal-title":"Case Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.18621\/eurj.304373","article-title":"Severe bone marrow suppression following single-dose methotrexate treatment for ectopic pregnancy","volume":"3","author":"D\u00fcndar","year":"2017","journal-title":"Eur. Res. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3899\/jrheum.080576","article-title":"Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity","volume":"36","author":"Fisher","year":"2009","journal-title":"J. rheumatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.therap.2015.12.006","article-title":"Fatal methotrexate toxicity in a patient treated for an ectopic pregnancy","volume":"71","author":"Ga\u00efes","year":"2016","journal-title":"Therapie"},{"key":"B8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41397-018-0047-z","article-title":"Genetic markers in methotrexate treatments","volume":"18","author":"Giletti","year":"2018","journal-title":"pharmacogenomics J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1060028016672035","article-title":"Interaction between low-dose methotrexate and nonsteroidal anti-inflammatory drugs, penicillins, and proton pump inhibitors: a narrative review of the literature","volume":"51","author":"Hall","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"B10","first-page":"599","article-title":"Ectopic pregnancy: diagnosis and management","volume":"101","author":"Hendriks","year":"2020","journal-title":"Am. Fam. physician"},{"key":"B11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2125.1996.tb00186.x","article-title":"Lack of interaction between flucloxacillin and methotrexate in pa tien ts with rheumatoid arthritis","volume":"41","author":"Herrick","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","article-title":"Preventing and managing toxicities of high-dose methotrexate","volume":"21","author":"Howard","year":"2016","journal-title":"Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/cpt.3329","article-title":"Comprehensive evaluation of OATP\u2010and BCRP\u2010mediated drug\u2013drug interactions of methotrexate using physiologically\u2010based pharmacokinetic modeling","volume":"116","author":"Hwang","year":"2024","journal-title":"Clin. Pharmacol. and Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/0029-7844(96)00252-9","article-title":"Life-threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases","volume":"88","author":"Isaacs","year":"1996","journal-title":"Obstetrics and Gynecol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/17425255.2023.2193325","article-title":"A critical review of methotrexate clinical interactions: role of transporters","volume":"19","author":"Jafari","year":"2023","journal-title":"Expert Opin. Drug Metabolism and Toxicol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"152909","DOI":"10.1016\/j.tox.2021.152909","article-title":"Molecular toxicity of methotrexate in rheumatoid arthritis treatment: a novel perspective and therapeutic implications","volume":"461","author":"Katturajan","year":"2021","journal-title":"Toxicology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/01.AOG.0000172374.72125.3e","article-title":"A cautionary tale: fatal outcome of methotrexate therapy given for management of ectopic pregnancy","volume":"107","author":"Kelly","year":"2006","journal-title":"Obstetrics and Gynecol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1177\/1078155220953878","article-title":"Significant interaction between high-dose methotrexate and high-dose piperacillin-tazobactam causing reversible neurotoxicity and renal failure in an osteosarcoma patient","volume":"27","author":"Kr\u00e4mer","year":"2021","journal-title":"J. Oncol. Pharm. Pract."},{"key":"B19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1586\/ecp.11.57","article-title":"Pharmacokinetic drug\u2013drug interactions with methotrexate in oncology","volume":"4","author":"Lev\u00eaque","year":"2011","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jcph.2454","article-title":"Pharmacokinetics and safety of intramuscular injectable benzathine penicillin g in Japanese healthy participants","volume":"64","author":"Li","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/rheumatology\/keh685","article-title":"Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years","volume":"44","author":"Lim","year":"2005","journal-title":"Rheumatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.5694\/j.1326-5377.1991.tb93847.x","article-title":"Neutropenia due to low\u2010dose methotrexate therapy for psoriasis and rheumatoid arthritis May be fatal","volume":"155","author":"Mayall","year":"1991","journal-title":"Med. J. Aust."},{"key":"B23","doi-asserted-by":"publisher","first-page":"17455057231160349","DOI":"10.1177\/17455057231160349","article-title":"Overview of ectopic pregnancy diagnosis, management, and innovation","volume":"19","author":"Mullany","year":"2023","journal-title":"Women's Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1097\/AOG.0000000000002560","article-title":"ACOG practice bulletin no. 193: tubal ectopic pregnancy","volume":"131","author":"Obstetricians","year":"2018","journal-title":"Obstetrics Gynecol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40738-015-0008-z","article-title":"Incidence, diagnosis and management of tubal and nontubal ectopic pregnancies: a review","volume":"1","author":"Panelli","year":"2015","journal-title":"Fertil. Res. Pract."},{"key":"B26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s13256-021-03111-x","article-title":"Methotrexate-induced toxidermia and pancytopenia in a patient with ectopic pregnancy: a case report","volume":"15","author":"Refeno","year":"2021","journal-title":"J. Med. Case Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12026-014-8564-6","article-title":"Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?","volume":"60","author":"Rom\u00e3o","year":"2014","journal-title":"Immunol. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00007691-199310000-00004","article-title":"Pharmacokinetic interaction between high-dose methotrexate and amoxycillin","volume":"15","author":"Ronchera","year":"1993","journal-title":"Ther. drug Monit."},{"key":"B29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40199-020-00379-0","article-title":"Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction","volume":"29","author":"Shafie","year":"2021","journal-title":"DARU J. Pharm. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/gtmb.2016.0326","article-title":"Association between MTHFR C677T polymorphism and methotrexate treatment outcome in rheumatoid arthritis patients: a systematic review and meta-analysis","volume":"21","author":"Shao","year":"2017","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"B31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5114\/aoms.2016.58844","article-title":"Methotrexate-induced pancytopenia in a patient with ectopic pregnancy","volume":"14","author":"Shao","year":"2018","journal-title":"Archives Med. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"757464","DOI":"10.3389\/fphar.2021.757464","article-title":"The role of genetic polymorphisms in high-dose methotrexate toxicity and response in hematological malignancies: a systematic review and meta-analysis","volume":"12","author":"Song","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4274\/tjod.80457","article-title":"Severe methotrexate toxicity after treatment for ectopic pregnancy: a case report","volume":"13","author":"Soysal","year":"2016","journal-title":"Turkish J. Obstetrics Gynecol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3390\/medicina60111900","article-title":"Methotrexate-induced toxicity after ultrasound-guided intragestational injection in a patient with caesarean scar pregnancy\u2014a case report","volume":"60","author":"Stavros","year":"2024","journal-title":"Medicina"},{"key":"B35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/GRF.0b013e3182510a35","article-title":"Methotrexate: the pharmacology behind medical treatment for ectopic pregnancy","volume":"55","author":"Stika","year":"2012","journal-title":"Clin. Obstetrics Gynecol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/pds.4555","article-title":"Concomitant use of low\u2010dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis","volume":"27","author":"Svanstr\u00f6m","year":"2018","journal-title":"Pharmacoepidemiol. drug Saf."},{"key":"B37","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1124\/jpet.102.034330","article-title":"Characterization of methotrexate transport and its drug interactions with human organic anion transporters","volume":"302","author":"Takeda","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/00007691-200208000-00018","article-title":"Pharmacokinetic interaction between high-dose methotrexate and oxacillin","volume":"24","author":"Titier","year":"2002","journal-title":"Ther. drug Monit."},{"key":"B39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","article-title":"Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review","volume":"158","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11096-019-00958-5","article-title":"Effect of proton pump inhibitors on high-dose methotrexate elimination: a systematic review and meta-analysis","volume":"42","author":"Wang","year":"2020","journal-title":"Int. J. Clin. Pharm."},{"key":"B41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00228-013-1608-3","article-title":"Almost a tragedy: severe methotrexate toxicity in a hemodialysis patient treated for ectopic pregnancy","volume":"70","author":"Willner","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1003812","DOI":"10.3389\/fphar.2022.1003812","article-title":"Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/106002809703101022","article-title":"Delayed elimination of methotrexate associated with piperacillin administration","volume":"31","author":"Yamamoto","year":"1997","journal-title":"Ann. Pharmacother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s13277-012-0395-2","article-title":"Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis","volume":"33","author":"Yang","year":"2012","journal-title":"Tumor Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"738315","DOI":"10.3389\/fmed.2021.738315","article-title":"Severe adverse toxic effects of low-dose methotrexate treatment on an ectopic pregnancy patient with methylenetetrahydrofolate reductase mutations: a case report","volume":"8","author":"Yu","year":"2021","journal-title":"Front. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/jac\/dkl196","article-title":"Pharmacokinetic interaction between methotrexate and piperacillin\/tazobactam resulting in prolonged toxic concentrations of methotrexate","volume":"58","author":"Zarychanski","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13256-023-03834-z","article-title":"Low-dose methotrexate-induced renal failure in a patient with ectopic pregnancy: a case report","volume":"17","author":"Zhang","year":"2023","journal-title":"J. Med. Case Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s43042-024-00562-x","article-title":"Relationship between the efficacy and adverse effects of methotrexate and gene polymorphism","volume":"25","author":"Zhao","year":"2024","journal-title":"Egypt. J. Med. Hum. Genet."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1671369\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:33:52Z","timestamp":1759383232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1671369\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":48,"alternative-id":["10.3389\/fphar.2025.1671369"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1671369","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fphar.2025.1671369.s001","asserted-by":"subject"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1671369"}}